Literature DB >> 8893727

A model of diffuse traumatic brain injury in the immature rat.

P D Adelson1, P Robichaud, R L Hamilton, P M Kochanek.   

Abstract

Diffuse cerebral swelling after severe traumatic brain injury (TBI) develops more commonly in children than adults; however, models of diffuse brain injury in immature animals are lacking. The authors developed a new model of diffuse severe TBI in immature rats by modifying a recently described closed head injury model for adult rats. A total of 105 Sprague-Dawley immature rats (17 days old; average weight 38.5 +/- 5.46 g) were subjected to head impact using variable weights (0 g (sham), 75 g, 100 g, or 125 g) delivered from a height of 2 m onto a metal disk cemented to the intact cranium. Mortality, physiological and neurological parameters (from early reflex recovery to escape), and early histopathological changes were assessed. During the acute period after severe injury (SI) (100 g delivered from a height of 2 m; 50 rats), apnea was frequently observed and the mortality rate was 38%. Neurological recovery was complete in the sham-injured animals (11 rats) by 4.1 +/- 0.23 minutes (mean +/- standard error of the mean), but was delayed in both moderately injured (MI) (75 g/2 m; 11 rats) (14.97 +/- 3.99 minutes) and SI (20.57 +/- 1.31 minutes (p < 0.05)) rats. In the first 24 hours, the sham-injured animals were more active than the injured ones as reflected by a greater net weight gain: 2.9 +/- 1.0 g, 1.2 +/- 1.6 g, and -0.6 +/- 2.1 g in sham-injured, MI, and SI animals, respectively. Immediately after injury, transient hypertension (lasting < 15 seconds) was followed by hypotension (lasting < 3 minutes) and loss of temperature regulation. Both injuries also induced apnea (0.75 +/- 0.7 minutes and 1.27 +/- 0.53 minutes in MI and SI groups, respectively), which either resolved or deteriorated to death. Intubation and assisted ventilation in animals with SI for 9.57 +/- 3.27 minutes in the peritrauma period eliminated mortality (p < 0.05, intubated vs. nonintubated). Histologically, after SI, there was diffuse edema throughout the corpus callosum below the region of injury and in the thalami. Other injuries included neuronal death in the deep nuclei, bilateral disruption of CA3, diffuse subarachnoid hemorrhage, and, in some, ventriculomegaly. Following a diffuse TBI in immature rats, SI produced a mortality rate, neurological deficit, and histological changes similar to those previously reported for an injury resulting from a 450-g weight dropped from 2 m in adult rats. A graded insult was achieved by maintaining the height of the weight drop but varying the weights. Weight loss, acute physiological instability, and acute neurological deficits were also indicative of an SI. Mortality was eliminated when ventilatory support was used during the peritrauma period. This model should be useful in studying the response of the immature rat to diffuse severe TBI.

Entities:  

Mesh:

Year:  1996        PMID: 8893727     DOI: 10.3171/jns.1996.85.5.0877

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  23 in total

Review 1.  Hypothermia following pediatric traumatic brain injury.

Authors:  P David Adelson
Journal:  J Neurotrauma       Date:  2009-03       Impact factor: 5.269

Review 2.  Therapeutic strategies to target acute and long-term sequelae of pediatric traumatic brain injury.

Authors:  Jimmy W Huh; Ramesh Raghupathi
Journal:  Neuropharmacology       Date:  2018-06-20       Impact factor: 5.250

3.  Mitochondrial respiratory chain and creatine kinase activities following trauma brain injury in brain of mice preconditioned with N-methyl-D-aspartate.

Authors:  Carina R Boeck; Leatrice S Carbonera; Mônia E Milioli; Leandra C Constantino; Michelle L Garcez; Gislaine T Rezin; Giselli Scaini; Emilio L Streck
Journal:  Mol Cell Biochem       Date:  2013-09-07       Impact factor: 3.396

4.  Harmonization of lateral fluid-percussion injury model production and post-injury monitoring in a preclinical multicenter biomarker discovery study on post-traumatic epileptogenesis.

Authors:  Xavier Ekolle Ndode-Ekane; Cesar Santana-Gomez; Pablo M Casillas-Espinosa; Idrish Ali; Rhys D Brady; Gregory Smith; Pedro Andrade; Riikka Immonen; Noora Puhakka; Matthew R Hudson; Emma L Braine; Sandy R Shultz; Richard J Staba; Terence J O'Brien; Asla Pitkänen
Journal:  Epilepsy Res       Date:  2019-01-18       Impact factor: 3.045

Review 5.  Preconditioning for traumatic brain injury.

Authors:  Shoji Yokobori; Anna T Mazzeo; Khadil Hosein; Shyam Gajavelli; W Dalton Dietrich; M Ross Bullock
Journal:  Transl Stroke Res       Date:  2012-11-15       Impact factor: 6.829

6.  A brief history of behavioral assessment following experimental traumatic brain injury in juveniles.

Authors:  Richard E Hartman
Journal:  Transl Stroke Res       Date:  2011-11-08       Impact factor: 6.829

7.  Glutathione peroxidase overexpression does not rescue impaired neurogenesis in the injured immature brain.

Authors:  Matthew B Potts; Radoslaw Rola; Catherine P Claus; Donna M Ferriero; John R Fike; Linda J Noble-Haeusslein
Journal:  J Neurosci Res       Date:  2009-06       Impact factor: 4.164

Review 8.  Found in translation: Understanding the biology and behavior of experimental traumatic brain injury.

Authors:  Corina O Bondi; Bridgette D Semple; Linda J Noble-Haeusslein; Nicole D Osier; Shaun W Carlson; C Edward Dixon; Christopher C Giza; Anthony E Kline
Journal:  Neurosci Biobehav Rev       Date:  2014-12-10       Impact factor: 8.989

Review 9.  Hitting a moving target: Basic mechanisms of recovery from acquired developmental brain injury.

Authors:  Christopher C Giza; Bryan Kolb; Neil G Harris; Robert F Asarnow; Mayumi L Prins
Journal:  Dev Neurorehabil       Date:  2009       Impact factor: 2.308

10.  Alterations in cerebral oxygen metabolism after traumatic brain injury in children.

Authors:  Dustin K Ragan; Robert McKinstry; Tammie Benzinger; Jeffrey R Leonard; Jose A Pineda
Journal:  J Cereb Blood Flow Metab       Date:  2012-09-12       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.